A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : AFP / alpha-fetoprotein

[Related PubMed/MEDLINE]
Total Number of Papers: 7557
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   AFP  (>> Co-occurring Abbreviation)
Long Form:   alpha-fetoprotein
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A novel chemoprotective effect of tiopronin against diethylnitrosamine-induced hepatocellular carcinoma in rats: Role of ASK1/P38 MAPK-P53 signalling cascade. DENA, HCC, phospho-ASK1
2020 Aberrant AFP expression characterizes a subset of hepatocellular carcinoma with distinct gene expression patterns and inferior prognosis. CEA, PSA
2020 Acetylation of alpha-fetoprotein promotes hepatocellular carcinoma progression. HBx, HCC, PA
2020 Adenocarcinosarcoma at the esophagogastric junction with long esophageal invasion: a case report. EGJ, HER2, PAS, SALL 4
2020 Alpha-fetoprotein is an autoantigen in hepatocellular carcinoma and juvenile Batten disease. BD, HCC
2020 Annual contrast-enhanced magnetic resonance imaging is highly effective in the surveillance of hepatocellular carcinoma among cirrhotic patients. HCC
2020 Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection. BCLC, HBsAg, HCC, HR, NSAIDs
2020 Carcinogenesis effects of E2F transcription factor 8 (E2F8) in hepatocellular carcinoma outcomes: an integrated bioinformatic report. AJCC, DSS, E2F8, GEO, GSEA, HCC, OS, PBMC, PFS, RFS
2020 Clinical Impact of Circulated miR-1291 in Plasma of Patients with Liver Cirrhosis (LC) and Hepatocellular Carcinoma (HCC): Implication on Glypican-3 Expression. HCC, LC, qRT-PCR
10  2020 Clinical value of LHPP-associated microRNAs combined with protein induced by vitamin K deficiency or antagonist-II in the diagnosis of alpha-fetoprotein-negative hepatocellular carcinoma. AFP-NHCC, HCC, miRs, PIVKA-II
11  2020 Coenzyme Q10 attenuates rat hepatocarcinogenesis via the reduction of CD59 expression and phospholipase D activity. Bcl-2, CASP3, CoQ10, ELISA, HCC, HMGCR, IHC, PCNA, PLD, sCD59, SR-B1, TNF
12  2020 Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological study of five cases. CAED, GPC3, SALL4
13  2020 Common and Rare Sequence Variants Influencing Tumor Biomarkers in Blood. ALP
14  2020 Comparison of chemoembolization with CalliSpheres microspheres and conventional chemoembolization in the treatment of hepatocellular carcinoma: a multicenter retrospective study. AEs, ALB, ALP, CR, cTACE, DCR, HCC, OS, PFS, TACE
15  2020 Correlating serum alpha-fetoprotein in hepatocellular carcinoma with response to Yttrium-90 transarterial radioembolization with glass microspheres (TheraSphere™). CI, DSS, HCC, OR
16  2020 Detection of circulating tumor cells and their implications as a novel biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma. CTCs, HCC
17  2020 Development and Identification of a Nomogram Prognostic Model for Patients with Primary Clear Cell Carcinoma of the Liver. CI, HCC, HR, OS, PCCCL, SEER
18  2020 Diagnosis efficacy of CEUS for hepatic inflammatory lesions. AP, DP, PVP, US
19  2020 Diagnostic efficacy of dynamic liver imaging using qualitative diagnostic algorithm versus LI-RADS v2018 lexicon for atypical versus classical HCC lesions: A decade of experience from a tertiary liver institute. HCC, LI-RADS, NPV, PLHR, PPV
20  2020 Diagnostic performance of a minimized protocol of non-contrast MRI for hepatocellular carcinoma surveillance. HCC
21  2020 Diagnostic Value of Serum Biomarkers for Patients Undergoing Curative Resection with Non-B, Non-C Hepatocellular Carcinoma. AUC, DCP, HBcAb, NBNC-HCC, ROC
22  2020 Dynamic Changes in Serum Markers and Their Utility in the Early Diagnosis of All Stages of Hepatitis B-Associated Hepatocellular Carcinoma. AUC, DCP, GP73, GPC3, HBV, HCC, ROC
23  2020 Effect of Diphtheria Toxin-Based Gene Therapy for Hepatocellular Carcinoma. DTA, HCC, YAP
24  2020 Effects of Natural Progesterone and Synthetic Progestin on Germ Layer Gene Expression in a Human Embryoid Body Model. cACT, CG, GATA4, hESCs, HNF, IVF, mBLs, MPA, qRT-PCR
25  2020 Efficiency of whole-body 18F-FDG PET CT in detecting the cause of rising serum AFP level in post-therapeutic follow-up for HCC patients. HCC
26  2020 Elevated Serum alpha-Fetoprotein is Associated with Abbreviated Survival for Patients with Fibrolamellar Hepatocellular Carcinoma Who Undergo a Curative Resection. FLC, HCC, HR, OS
27  2020 Elucidating Binding Sites and Affinities of ERalpha Agonists and Antagonists to Human Alpha-Fetoprotein by In Silico Modeling and Point Mutagenesis. ER, hAFP, MD, MM/GBSA
28  2020 Enhancing biosensing sensitivity of metal nanostructures through site-selective binding. EM, GNTC, LSPR
29  2020 Evaluation of Different Blood Circulating miRNAs for Hepatocellular Carcinoma Diagnosis. ---
30  2020 Evaluation of miR-331-3p and miR-23b-3p as serum biomarkers for hepatitis c virus-related hepatocellular carcinoma at early stage. AUC, CLD, HC, HCC, HCV
31  2020 Experience With LDLT in Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis Postdownstaging. DS, HCC, LDLT, LT, OS, PVTT, SBRT
32  2020 GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis. AFP-L3, AUC, DCP, HCC, NASH
33  2020 Glutamine synthetase promotes tumor invasion in hepatocellular carcinoma through mediating epithelial-mesenchymal transition. GS, HCC
34  2020 Hepatic ameliorative role of vitamin B17 against Ehrlich ascites carcinoma-induced liver toxicity. EAC, VB17
35  2020 Hepatitis B virus X protein upregulates alpha-fetoprotein to promote hepatocellular carcinoma by targeting miR-1236 and miR-329. HBV, HBx, HCC
36  2020 Hepatocellular Carcinoma and Liver Transplantation: A Single-Center Experience. HCC, LDLT, LT, MELD
37  2020 HNF-1 binding point mutation of the AFP gene promotes cirrhosis in post-menopausal women. HNF1
38  2020 Identification of an Upper Limit of Tumor Burden for Downstaging in Candidates with Hepatocellular Cancer Waiting for Liver Transplantation: A West-East Collaborative Effort. HCC, LT
39  2020 Inducing differentiation of human urine-derived stem cells into hepatocyte-like cells by coculturing with human hepatocyte L02 cells. ALB, CYP450, hUSCs
40  2020 Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease. DCP
41  2020 Liver transplantation for hepatocellular carcinoma after successful treatment of macrovascular invasion - a multi-center retrospective cohort study. HCC
42  2020 Mass Spectrometric Assay of Alpha-Fetoprotein Isoforms for Accurate Serological Evaluation. AFP-L3, HCC, LODs
43  2020 Metabolism-associated molecular classification of hepatocellular carcinoma. HCC
44  2020 Methylation of tumour suppressor genes RUNX3, RASSF1A and E-Cadherin in HCV-related liver cirrhosis and hepatocellular carcinoma. HCC
45  2020 MicroRNAs as Appropriate Discriminators in Non-Specific Alpha-Fetoprotein (AFP) Elevation in Testicular Germ Cell Tumor Patients. TGCTs
46  2020 Mixed Germ Cell Tumor of the Endometrium: A Case Report and Literature Review. GCTs, PLAP
47  2020 Multi-marker diagnosis method for early Hepatocellular Carcinoma based on surface plasmon resonance. DASM, HCC, SPR
48  2020 Multimodal Percutaneous Thermal Ablation of Small Hepatocellular Carcinoma: Predictive Factors of Recurrence and Survival in Western Patients. ASA, HCCs, HR, IDR, LTP, PTA
49  2020 Multiplexed Proteomic Approach for Identification of Serum Biomarkers in Hepatocellular Carcinoma Patients with Normal AFP. HCC, MRM, Trim22
50  2020 Nomogram based on inflammatory indices for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma. ANRI, DCA, HCC, ICC, ROC
51  2020 Nomograms to predict the long-time prognosis in patients with alpha-fetoprotein negative hepatocellular carcinoma following radical resection. C-index, DCA, HCC
52  2020 Options for the treatment of intrahepatic recurrent hepatocellular carcinoma: salvage liver transplantation or rehepatectomy? OS, RFS, RH, sLT
53  2020 Palliative Liver Radiotherapy (RT) for Symptomatic Hepatocellular Carcinoma (HCC). HCC, RT, SBRT, TACE
54  2020 Paper-based colorimetric spot test utilizing smartphone sensing for detection of biomarkers. Ab, BSA, IgG, LOD, MUC16, NC, POC
55  2020 Pituitary stalk enlargement in adults. ACE, DI
56  2020 Plasma circular RNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma: A large-scale, multicenter study. AUC, CircPanel, circRNAs, HBV, HCC
57  2020 Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma. ALBI, HCC, ICIs, ORR, OS
58  2020 Preeclampsia: risk factors and neonatal outcomes associated with early- versus late-onset diseases. EOPE, LOPE
59  2020 Prenatal Biochemical Screening and a Woman's Long-Term Risk of Cancer: A Population-Based Cohort Study. aHR, CI, hCG, MoM
60  2020 Preparation of Aptamer Responsive DNA Functionalized Hydrogels for the Sensitive Detection of alpha-Fetoprotein Using SERS Method. HCC, IgG
61  2020 Prognostic value of serum microRNA-122 in hepatocellular carcinoma is dependent on coexisting clinical and laboratory factors. BCLC, HCC, miR-122
62  2020 Prostate-specific Membrane Antigen-expressing Hepatic Lesion: Metastatic or Hepatocellular Carcinoma. HCC, PSA, PSMA
63  2020 Protocol For An Adjuvant Alpha-Fetoprotein-Derived Peptide After Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma: Safety Study. HCC, IRRID, TACE
64  2020 Radiological features and outcomes ofcombined hepatocellular-cholangiocarcinoma inpatients undergoingsurgical resection. cHCC-CCA, CT, DFS, HCC, ICC, MRI, OS
65  2020 Ramucirumab after prior sorafenib in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Japanese subgroup analysis of the REACH-2 trial. CI, HCC, HR, OS, PFS
66  2020 Rapid fabrication of electrode for the detection of alpha fetoprotein based on MnO2 functionalized mesoporous carbon hollow sphere. CV, EIS, HRTEM, SEM, XRD
67  2020 Self-Powered Temperature Sensor with Seebeck Effect Transduction for Photothermal-Thermoelectric Coupled Immunoassay. GOx, NIR, oxTMB, TMB
68  2020 Sequential Circulating Tumor Cell Counts in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: Monitoring the Treatment Response. CTCs, HCC, PR, SD
69  2020 Significance of a preoperative tumor marker gradient for predicting microvascular invasion in cases of hepatocellular carcinoma. HCC
70  2020 Simultaneous Detection of Multiple Tumor Markers in Blood by Functional Liquid Crystal Sensors Assisted with Target-Induced Dissociation of Aptamer. CEA, LC, MBs, PSA, TID
71  2020 Spontaneous regression of hepatocellular carcinoma: myth or reality? HCC
72  2020 The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection. ALBI, HCC, LC, OS, RFS
73  2020 The expression level and diagnostic value of microRNA-22 in HCC patients. ALT, AST, HCC, miR-22, qRT-PCR, ROC
74  2020 The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis. AUC, HCC, SROC
75  2020 The Utility of Retinol-Binding Protein 4 in Predicting Liver Fibrosis in Chronic Hepatitis C Patients in Response to Direct-Acting Antivirals. CHC, DAAs, PLR, RBP4
76  2020 Thiamin Regresses the Anticancer Efficacy of Methotrexate in the Amelioration of Diethyl Nitrosamine-Induced Hepatocellular Carcinoma in Wistar Strain Rats. ALP, ALT, AST, CAT, DC, DEN, GPx, HCC, i.p, LPO, MTX, NC, SOD, TB, TP, VEGF
77  2020 TUG1 Is a Regulator of AFP and Serves as Prognostic Marker in Non-Hepatitis B Non-Hepatitis C Hepatocellular Carcinoma. CRISPR, HCC, lncRNAs, NBNC-HCC, TUG1
78  2020 Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: A systematic review and meta-analysis. AUC, ctDNA, DOR, HCC, NLR, PLR, SEN, SPE, SROC
79  2020 Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines. BCLC, CART, CCS, CI, HCC, HR, OS, TBS
80  2020 Van Wyk-Grumbach syndrome in a female pediatric patient with trisomy 21: a case report. TSH
81  2020 Vessels Encapsulating Tumor Clusters (VETC) Is a Powerful Predictor of Aggressive Hepatocellular Carcinoma. HCC, HR, VETC, VETC
82  2020 Yolk Sac Tumors of the Head and Neck in Aicardi Syndrome. YSTs
83  2020 [Diagnostic and prognostic significance of alpha-fetoprotein in hepatocellular carcinoma]. HCC
84  2020 [Value of serum alpha-fetoprotein for the prognostic evaluation of hepatitis B virus-related acute-on-chronic liver failure treated with artificial liver]. AUC, HBV-ACLF, ROC
85  2019 A biomimetic fluorescent nanosensor based on imprinted polymers modified with carbon dots for sensitive detection of alpha-fetoprotein in clinical samples. APS, LOD, MBA, NIPAM, RSDs, V-CDs, VPBA
86  2019 A Case Report: Can Citrin Deficiency Lead to Hepatocellular Carcinoma in Children? DWI, FTTDCD, HCC, MRI
87  2019 A Case Study on Chronic Hepatitis-C Viral infection Associated with Hepatocellular Carcinoma in a Tertiary Hospital of Bangladesh. HCC
88  2019 A Clinical Scoring System for Predicting Microvascular Invasion in Patients with Hepatocellular Carcinoma Within the Milan Criteria. DCP, Gd-EOB-DTPA, HCC, MRI, MVI, OR
89  2019 A combination of alpha-fetoprotein, midkine, thioredoxin and a metabolite for predicting hepatocellular carcinoma. AUC, GC-MS, HCC
90  2019 A fluorometric aptamer nanoprobe for alpha-fetoprotein by exploiting the FRET between 5-carboxyfluorescein and palladium nanoparticles. FRET, HCC, PdNPs
91  2019 A Large-Scale Multicenter Study Validates Aldo-Keto Reductase Family 1 Member B10 as a Prevalent Serum Marker for Detection of Hepatocellular Carcinoma. AKR1B10, AUC, BLTs, CHB, HCC, HCs, LC, ROC
92  2019 A magneto-microfluidic platform for fluorescence immunosensing using quantum dot nanoparticles. CEA
93  2019 A nomogram based on bi-regional radiomics features from multimodal magnetic resonance imaging for preoperative prediction of microvascular invasion in hepatocellular carcinoma. DCE, HCC, MRI, mRMR, MVI
94  2019 A novel analysis method for biomarker identification based on horizontal relationship: identifying potential biomarkers from large-scale hepatocellular carcinoma metabolomics data. AUC, DNB-HC, HCC, ROC
95  2019 A novel ECL sensor based on a boronate affinity molecular imprinting technique and functionalized SiO2@CQDs/AuNPs/MPBA nanocomposites for sensitive determination of alpha-fetoprotein. CQDs, ECL, MIP, MPBA
96  2019 A Novel Online Calculator Based on Serum Biomarkers to Detect Hepatocellular Carcinoma among Patients with Hepatitis B. AFU, AUC, CHB, HBV, HBV-LC, HCC, HCs, PIVKA-II
97  2019 A novel prognostic score model based on combining systemic and hepatic inflammation markers in the prognosis of HBV-associated hepatocellular carcinoma patients. APRI, AUC, gamma-GT, HBV, HCC, NLR, PLR, PNI, ROC, TNM
98  2019 A prognostic fingerprint in liver transplantation for hepatocellular carcinoma based on plasma metabolomics profiling. HC, HCC, LC, NLR, PC
99  2019 A prognostic model for hepatitis B acute-on-chronic liver failure patients treated using a plasma exchange-centered liver support system. ALSS, APM, HBV-ACLF, INR, PE
100  2019 A rat model of placental inflammation explains the unexplained elevated maternal serum alpha-fetoprotein associated with adverse pregnancy outcomes. APO, LPS, MSAFP